United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8605_48cbeb9b-de13-4330-97b2-f87fb7e26cb9
- Product NDC
- 68788-8605
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240313
- Source listing expiry
- 20271231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 TABLET in 1 BOTTLE (68788-8605-0) · 68788-8605-0
- 14 TABLET in 1 BOTTLE (68788-8605-1) · 68788-8605-1
- 30 TABLET in 1 BOTTLE (68788-8605-3) · 68788-8605-3
- 15 TABLET in 1 BOTTLE (68788-8605-5) · 68788-8605-5
- 90 TABLET in 1 BOTTLE (68788-8605-9) · 68788-8605-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →